Company intelligence
Seek Labs
Every disease has a sequence. Decode it. Program against it. Target what it can’t change.
About Seek Labs
Seek Labs is building a programmable disease-response platform. One AI engine. Two deployment paths across therapeutics and diagnostics. A new way to fight disease. • BioSeeker decodes disease-associated genomic sequences and identifies conserved vulnerabilities. • PTAP programs those insights into Sequence Ablation Therapeutics (SAT), a new class of programmable therapeutics. • SeekIt brings molecular detection to the point of need. Decode. Program. Resolve. We’ve already started. 145+ diseases decoded by BioSeeker. When a new pathogen emerges, Seek Labs is not at day zero. This is a platform, not a single drug, built for infectious disease, global health, and emerging threats. Learn more at www.seek.labs.com.
Verified activity
Signals from Seek Labs
2 published signals
Presence & Recognition
Seek Labs won the Innovation winner award in the BioTech/Therapeutics category for Sequence Ablation Technology.
Reported by Alison O'Mahony
Presence & Recognition
Seek Labs was named the first-place winner in the BioTech and Therapeutics category of the 2026 Utah Business Innovation Awards presented by Utah Business.
Reported by Seek Labs